Cytognomix creates and and sells novel genome bioinformatic products for diagnostic applications. We find and validate mutations that others cannot.
Cytognomix is a London, Ontario based biotechnology company developing software-based solutions and reagents for clinical genomics. The company has a significant intellectual property portfolio, which emphasizes products for clinical diagnostic applications. Current products include mutation interpretation software, DNA probe reagents and companion software, and software for estimating radiation dose from DNA damage.